Circulating circRNA in Acute Ischemic Stroke
NCT05098340 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-08-06
Summary
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Conditions
- Acute Ischemic Stroke
Interventions
- GENETIC
-
Quantitative Real-time polymerase chain reaction
Quantitative Real-time polymerase chain reaction of circular RNA (circRNA).
Sponsors & Collaborators
-
The Affiliated Hospital of Xuzhou Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2024-10-30
- Completion
- 2024-10-30
Countries
- China
Study Locations
More Related Trials
-
PG2 Injection 500 mg in Acute Stroke Study (Pass)
NCT01603667 ·Status: COMPLETED ·Phase: PHASE2
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
NCT04676659 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment
NCT06848894 ·Status: RECRUITING ·Phase: NA
-
The Efficacy and Safety Study of ALbumin Therapy in Acute Ischemic Stroke
NCT01684462 ·Status: TERMINATED ·Phase: PHASE2
-
Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;
NCT04290494 ·Status: COMPLETED
-
Effect of Rosuvastatin on Prognosis of Clinical Response in Acute Ischemic Stroke Patients(REPAIRS)
NCT02484027 ·Status: UNKNOWN ·Phase: PHASE4
-
Butyphthalide in Combination With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
NCT03394950 ·Status: COMPLETED ·Phase: PHASE4
-
BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)
NCT00206908 ·Status: COMPLETED
-
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
NCT07233070 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of r-PA Treating Patients With Acute Ischemic Stroke（RAISE）
NCT05295173 ·Status: COMPLETED ·Phase: PHASE3
-
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase
NCT04086147 ·Status: COMPLETED ·Phase: PHASE2
-
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
NCT03541668 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
NCT03578822 ·Status: COMPLETED ·Phase: PHASE3
-
An Exploratory Study of Ganglioside GM1 in Acute Ischemic Stroke
NCT04952064 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset
NCT07094763 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endovascular Therapy for Acute Ischemic Stroke Trial
NCT02350283 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Acute Ischemic Stroke
NCT05993884 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke
NCT07163702 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
NCT05445895 ·Status: COMPLETED ·Phase: PHASE4
-
BXOS110 Injection in the Treatment of Acute Ischaemic Stroke
NCT06322394 ·Status: RECRUITING ·Phase: PHASE2
-
Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy
NCT05700097 ·Status: UNKNOWN ·Phase: PHASE2
-
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II
NCT04516993 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)
NCT07119021 ·Status: RECRUITING ·Phase: PHASE4